World Health Organization: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010 2010. Accessed September 15, 2012, at
http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf
Google Scholar
Matovu JK, Makumbi FE: Expanding access to voluntary HIV counselling and testing in sub-Saharan Africa: alternative approaches for improving uptake, 2001–2007. Trop Med Int Health 2007, 12: 1315–1322. 10.1111/j.1365-3156.2007.01923.x
Article
PubMed
Google Scholar
Muhamadi L, Xavier N, Mbona TN, Wabwire-Mangen F, Anna-Mia E, Stefan P, George P: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: Policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD < 350 cells/muL) in eastern Uganda. Health Policy 2010, 97: 187–194. 10.1016/j.healthpol.2010.06.003
Article
PubMed
Google Scholar
Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R: Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health 2008, 13: 904–913. 10.1111/j.1365-3156.2008.02091.x
Article
PubMed
Google Scholar
Wasswa H: Ugandan hospitals ration AIDS treatment as antiretrovirals start to run out. BMJ 2010, 341: c3900. 10.1136/bmj.c3900
Article
PubMed
Google Scholar
World Health Organization: Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision 2010. Accessed September 15, 2012, at
http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf
Google Scholar
Kates J, Boortz K, Lief E, Avila C, Gobet B: Financing the response to AIDS in low- and middle-income countries: International assistance from the G8, European Commission and other donor governments in 2009. 2010. Accessed September 15, 2012, at
http://www.kff.org/hivaids/upload/7347–052.pdf
Google Scholar
Anglaret X, Chene G, Attia A, Touré S, Lafont S, Combe P, Manlan K, N’Dri-Yoman T, Salamon R: Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial Cotrimo-CI Study Group. Lancet 1999, 353: 1463–1468. 10.1016/S0140-6736(98)07399-1
Article
CAS
PubMed
Google Scholar
Minga A, Danel C, Abo Y, Dohoun L, Bonard D, Coulibaly A, Duvignac J, Dabis F, Salamon R, Anglaret X: Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d’Ivoire. Bull World Health Organ 2007, 85: 116–123. 10.2471/BLT.06.032292
Article
PubMed Central
PubMed
Google Scholar
Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X: Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis. AIDS Res Hum Retroviruses 2007, 23: 1338–1347. 10.1089/aid.2006.0308
Article
PubMed
Google Scholar
Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA: Cost-effectiveness of HIV treatment in resource-poor settings–the case of Côte d’Ivoire. N Engl J Med 2006, 355: 1141–1153. 10.1056/NEJMsa060247
Article
CAS
PubMed
Google Scholar
Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, Mercincavage LM, Touré S, Divi N, Anglaret X, Goldie SJ, Freedberg KA: HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS 2007, 21: 973–982. 10.1097/QAD.0b013e328011ec53
Article
PubMed Central
PubMed
Google Scholar
Kimmel AD, Weinstein MC, Anglaret X, Goldie SJ, Losina E, Yazdanpanah Y, Messou E, Cotich KL, Walensky RP, Freedberg KA: Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr 2010, 54: 258–268. 10.1097/QAI.0b013e3181d0db97
Article
CAS
PubMed Central
PubMed
Google Scholar
Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA: Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d’Ivoire appraisal. PLoS Med 2009, 6: e1000173. 10.1371/journal.pmed.1000173
Article
PubMed Central
PubMed
Google Scholar
Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, et al.: Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126: 946–954.
Article
CAS
PubMed
Google Scholar
Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, Weiss L: Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med 2000, 133: 401–410.
Article
CAS
PubMed
Google Scholar
Losina E, Yazdanpanah Y, Deuffic-Burban S, Wang B, Wolf LL, Messou E, Gabillard D, Seyler C, Freedberg KA, Anglaret X: The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d’Ivoire. Antivir Ther 2007, 12: 543–551.
CAS
PubMed Central
PubMed
Google Scholar
Touré S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, Diakite N, Karcher S, Grundmann C, Marlink R, et al.: Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d’Ivoire: 2-year outcomes and determinants. AIDS 2008, 22: 873–882. 10.1097/QAD.0b013e3282f768f8
Article
PubMed Central
PubMed
Google Scholar
Seyler C, Anglaret X, Dakoury-Dogbo N, Messou E, Touré S, Danel C, Diakite N, Daudie A, Inwoley A, Maurice C, et al.: Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d’Ivoire. Antivir Ther 2003, 8: 385–393.
PubMed
Google Scholar
El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, et al.: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006, 355: 2283–2296.
Article
CAS
PubMed
Google Scholar
Lopez AD: World Health Organization: World mortality in 2000: life tables for 191 countries. World Health Organization, Geneva; 2002.
Google Scholar
Messou E, Kouakou M, Gabillard D, Gouessé P, Koné M, Tchehy T, Losina E, Freedberg KA, Anzian A, Toure S, Anglaret X: Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d’Ivoire. J Acquir Immune Defic Syndr 2011,57(Suppl 1):S34-S39.
Article
PubMed Central
PubMed
Google Scholar
Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, Ekpini RE: The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect 2008,84(Suppl 1):i24-i30.
Article
PubMed Central
PubMed
Google Scholar
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance: Epidemiological fact sheets on HIV and AIDS. core data on epidemiology and response. Côte d’Ivoire; 2008. update. 2008. Accessed September 15, 2012, at
http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_CI.pdf
Google Scholar
World Health Organization: Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach. 2006 revision 2006. Accessed September 15, 2012, at
http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf
Google Scholar
Boulle A, Bock P, Osler M, Cohen K, Channing L, Hilderbrand K, Mothibi E, Zweigenthal V, Slingers N, Cloete K, Abdullah F: Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ 2008, 86: 678–687. 10.2471/BLT.07.045294
Article
PubMed Central
PubMed
Google Scholar
Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N: Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. AIDS 2012, 26: 929–938. 10.1097/QAD.0b013e328351f5b2
Article
CAS
PubMed
Google Scholar
Kantor R, Diero L, Delong A, Kamle L, Muyonga S, Mambo F, Walumbe E, Emonyi W, Chan P, Carter EJ, et al.: Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clin Infect Dis 2009, 49: 454–462. 10.1086/600396
Article
CAS
PubMed
Google Scholar
Goddard M, Hauck K, Smith PC: Priority setting in health - a political economy perspective. Health Econ Policy Law 2006, 1: 79–90.
Article
PubMed
Google Scholar
McCaughey D, Bruning NS: Rationality versus reality: the challenges of evidence-based decision making for health policy makers. Implement Sci 2010, 5: 39. 10.1186/1748-5908-5-39
Article
PubMed Central
PubMed
Google Scholar
Robinson R: Limits to rationality: economics, economists and priority setting. Health Policy 1999, 49: 13–26. 10.1016/S0168-8510(99)00040-8
Article
CAS
PubMed
Google Scholar
Mechanic D: Muddling through elegantly: finding the proper balance in rationing. Health Aff (Millwood) 1997, 16: 83–92. 10.1377/hlthaff.16.5.83
Article
CAS
Google Scholar
Mechanic D: Managed care and the imperative for a new professional ethic. Health Aff (Millwood) 2000, 19: 100–111. 10.1377/hlthaff.19.5.100
Article
CAS
Google Scholar
Ham C, Coulter A: Explicit and implicit rationing: taking responsibility and avoiding blame for health care choices. J Health Serv Res Policy 2001, 6: 163–169. 10.1258/1355819011927422
Article
CAS
PubMed
Google Scholar
Fox MP, Rosen S: Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 2010,15(Suppl 1):1–15.
Article
PubMed Central
PubMed
Google Scholar
Laurent C, Diakhate N, Gueye NF, Toure MA, Sow PS, Faye MA, Gueye M, Laniece I, Toure Kane C, Liegeois F, et al.: The Senegalese government’s highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 2002, 16: 1363–1370. 10.1097/00002030-200207050-00008
Article
PubMed
Google Scholar
Laurent C, Kouanfack C, Koulla-Shiro S, Nkoue N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, et al.: Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 2004, 364: 29–34. 10.1016/S0140-6736(04)16586-0
Article
CAS
PubMed
Google Scholar
Hammond R, Harry TC: Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures – a meta-analysis. Int J STD AIDS 2008, 19: 291–296. 10.1258/ijsa.2007.007248
Article
PubMed
Google Scholar
Moszynski P: Global Fund suspends new projects until 2014 because of lack of funding. BMJ 2011, 343: d7755. 10.1136/bmj.d7755
Article
PubMed
Google Scholar
UNAIDS/WHO: AIDS epidemic update. 2009. Accessed September 15, 2009, at
http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf
Google Scholar
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al.: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365: 493–505. 10.1056/NEJMoa1105243
Article
CAS
PubMed Central
PubMed
Google Scholar
Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C: Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010, 375: 2092–2098. 10.1016/S0140-6736(10)60705-2
Article
PubMed Central
PubMed
Google Scholar
Keiser O, Anastos K, Schechter M, Balestre E, Myer L, Boulle A, Bangsberg D, Toure H, Braitstein P, Sprinz E, et al.: Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 2008, 13: 870–879.
Article
CAS
PubMed
Google Scholar